Eosinophilic pneumonia due to duloxetine

Chest

Volumn 131, Issue 3, 2007, Pages 901-903

  Espeleta, Vidal J ^a   Moore, William H ^a   Kane, Philip B ^a   Baram, Daniel ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Antidepressant; Drug induced lung disease; Eosinophilic lung disease

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ATOMOXETINE; DULOXETINE; MULTIVITAMIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILL; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG INDUCED DISEASE; FEVER; HUMAN; LEUKOCYTE COUNT; LOEFFLER PNEUMONIA; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME;

EID: 33947405746     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1659     Document Type: Article

References (5)

1. Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med 2004; 25:77-88
2. Fleisch MC, Blauer F, Gubler JG, et al. Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment. Eur Respir J 2000; 15:205-208
3. Miyazaki E, Nureki S-i, Fukami T, et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 2002; 165:1125-1131
4. Foucher P, Camus P, Groupe d'Etudes de la Pathologie Pulmonaire Iatrogène. The drug-induced lung diseases. Available at: www.pneumotox.com. Accessed June 1, 2006
5. Duloxetine [package insert]. Indianapolis, IN: Eli Lilly, 2005